<?xml version='1.0' encoding='UTF-8'?><xml><records><record><source-app name="HighWire" version="7.x">Drupal-HighWire</source-app><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Jacobson, Anne</style></author></authors><secondary-authors><author><style face="normal" font="default" size="100%">Duckworth, William</style></author></secondary-authors></contributors><titles><title><style face="normal" font="default" size="100%">Intensive Therapy Fails to Improve Cardiovascular Outcomes in High-Risk Patients</style></title><secondary-title><style face="normal" font="default" size="100%">MD Conference Express</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2008</style></year><pub-dates><date><style  face="normal" font="default" size="100%">2008-10-01 00:00:00</style></date></pub-dates></dates><pages><style  face="normal" font="default" size="100%">13-14</style></pages><abstract><style  face="normal" font="default" size="100%">Intensive glucose-lowering therapy, defined as aiming for HbA1C levels below 7%, improves glycemic control among high-risk patients with type 2 diabetes mellitus. However, it has no long-term effect on cardiovascular outcomes in this patient population, according to findings from the Veterans Affairs Diabetes Trial [VADT].</style></abstract><number><style face="normal" font="default" size="100%">7</style></number><volume><style face="normal" font="default" size="100%">8</style></volume></record></records></xml>